April 2020
As the impact of the global COVID-19 pandemic hits hard and fast, PharmaTimes is open for business as usual and our team remains steadfast in its aim to seek out and deliver high-quality, credible news relevant to pharma and...
Read MoreSearch Results for: Lev Gerlovin and Pascale Diesel
Unlocking value
How cell and gene therapies are driving new deals in life sciences
- Cambridge researchers develop robotic nerve devices for neurological conditions
- International phase 3 clinical trial for new melanoma treatment recruits first patients
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
